{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:07:22Z","timestamp":1765040842170},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japan Research Foundation for Healthy Aging","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3182-1","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T13:03:32Z","timestamp":1548680612000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of clinical outcomes following percutaneous coronary intervention versus optimal medical therapy based on gray-zone fractional flow reserve in stable angina patients with intermediate coronary artery stenosis (COMFORTABLE prospective study): Study protocol for a multicenter randomized controlled trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Hironori","family":"Kitabata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutsugu","family":"Shiono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Shimamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Komukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Sougawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Gohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikazu","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Obana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuisa","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"3182_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1056\/NEJM199606273342604","volume":"334","author":"NH Pijls","year":"1996","unstructured":"Pijls NH, De Bruyne B, Peels K, Van Der Voort PH, Bonnier HJ, Bartunek J, Koolen JJ, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703\u20138.","journal-title":"N Engl J Med"},{"key":"3182_CR2","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","volume":"49","author":"NH Pijls","year":"2007","unstructured":"Pijls NH, Van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, Van\u2019t Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol. 2007;49:2105\u201311.","journal-title":"J Am Coll Cardiol"},{"key":"3182_CR3","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","volume":"36","author":"FM Zimmermann","year":"2015","unstructured":"Zimmermann FM, Ferrara A, Johnson NP, Van Nunen LX, Escaned J, Albertsson P, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Eur Heart J. 2015;36:3182\u20138.","journal-title":"Eur Heart J"},{"key":"3182_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa0807611","volume":"360","author":"PA Tonino","year":"2009","unstructured":"Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, Van\u2019t Veer M, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213\u201324.","journal-title":"N Engl J Med"},{"key":"3182_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","volume":"56","author":"NH Pijls","year":"2010","unstructured":"Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56:177\u201384.","journal-title":"J Am Coll Cardiol"},{"key":"3182_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B Bruyne De","year":"2012","unstructured":"De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991\u20131001.","journal-title":"N Engl J Med"},{"key":"3182_CR7","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1056\/NEJMoa1408758","volume":"371","author":"B Bruyne De","year":"2014","unstructured":"De Bruyne B, Fearon WF, Pijls NH, Barbato E, Tonino P, Piroth Z, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371:1208\u201317.","journal-title":"N Engl J Med"},{"key":"3182_CR8","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0140-6736(15)00057-4","volume":"386","author":"LX Nunen Van","year":"2015","unstructured":"Van Nunen LX, Zimmermann FM, Tonino PA, Barbato E, Baumbach A, Engstr\u00f8m T, et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet. 2015;386:1853\u201360.","journal-title":"Lancet"},{"key":"3182_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ccd.21406","volume":"71","author":"J Courtis","year":"2008","unstructured":"Courtis J, Rod\u00e9s-Cabau J, Larose E, D\u00e9ry J-P, Nguyen CM, Proulx G, et al. Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements. Catheter Cardiovasc Interv. 2008;71:541\u20138.","journal-title":"Catheter Cardiovasc Interv"},{"key":"3182_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/clc.20693","volume":"33","author":"M Lindstaedt","year":"2010","unstructured":"Lindstaedt M, Halilcavusogullari Y, Yazar A, Holland-Letz T, Bojara W, M\u00fcgge A, et al. Clinical outcome following conservative vs revascularization therapy in patients with stable coronary artery disease and borderline fractional flow reserve measurements. Clin Cardiol. 2010;33:77\u201383.","journal-title":"Clin Cardiol"},{"key":"3182_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jcin.2012.10.014","volume":"6","author":"R Petraco","year":"2013","unstructured":"Petraco R, Sen S, Nijjer S, Echavarria-Pinto M, Escaned J, Francis DP, et al. Fractional flow reserve-guided revascularization: practical implications of a diagnostic gray zone and measurement variability on clinical decisions. JACC Cardiovasc Interv. 2013;6:222\u20135.","journal-title":"JACC Cardiovasc Interv"},{"key":"3182_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1253\/circj.CJ-14-0671","volume":"79","author":"Y Shiono","year":"2014","unstructured":"Shiono Y, Kubo T, Tanaka A, Ino Y, Yamaguchi T, Tanimoto T, et al. Long-term outcome after deferral of revascularization in patients with intermediate coronary stenosis and gray-zone fractional flow reserve. Circ J. 2014;79:91\u20135.","journal-title":"Circ J"},{"key":"3182_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12928-014-0302-4","volume":"30","author":"J Yamashita","year":"2015","unstructured":"Yamashita J, Tanaka N, Shindo N, Ogawa M, Kimura Y, Sakoda K, et al. Seven-year clinical outcomes of patients with moderate coronary artery stenosis after deferral of revascularization based on gray-zone fractional flow reserve. Cardiovasc Interv Ther. 2015;30:209\u201315.","journal-title":"Cardiovasc Interv Ther"},{"key":"3182_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.115.018747","volume":"133","author":"J Adjedj","year":"2016","unstructured":"Adjedj J, De Bruyne B, Flore V, Di Gioia G, Ferrara A, Pellicano M, et al. Significance of intermediate values of fractional flow reserve in patients with coronary artery disease. Circulation. 2016;133:502\u20138.","journal-title":"Circulation"},{"key":"3182_CR15","first-page":"371","volume":"29","author":"SK Agarwal","year":"2017","unstructured":"Agarwal SK, Kasula S, Edupuganti MM, Raina S, Shailesh F, Almomani A, et al. Clinical decision-making for the hemodynamic \u201cgray zone\u201d (FFR 0.75-0.80) and long-term outcomes. J Invasive Cardiol. 2017;29:371\u20136.","journal-title":"J Invasive Cardiol"},{"key":"3182_CR16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1093\/eurheartj\/ehy079","volume":"39","author":"DY Kang","year":"2018","unstructured":"Kang DY, Ahn JM, Lee CH, Lee PH, Park DW, Kang SJ, et al. Deferred vs. performed revascularization for coronary stenosis with grey-zone fractional flow reserve values: data from the IRIS-FFR registry. Eur Heart J. 2018;39:1610\u20139.","journal-title":"Eur Heart J"},{"key":"3182_CR17","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1253\/circj.CJ-18-0672","volume":"82","author":"T Kubo","year":"2018","unstructured":"Kubo T, Takahata M, Terada K, Mori K, Arita Y, Ino Y, et al. Retrospective comparison of long-term clinical outcomes between percutaneous coronary intervention and medical therapy in stable coronary artery disease with gray zone fractional flow reserve - COMFORTABLE retrospective study. Circ J. 2018;82:3044\u201351.","journal-title":"Circ J"},{"key":"3182_CR18","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, et al. Clinical end points in coronary stent trials: a case of standardized definitions. Circulation. 2007;115:2344\u201351.","journal-title":"Circulation"},{"key":"3182_CR19","first-page":"580","volume":"26","author":"H Matsumoto","year":"2014","unstructured":"Matsumoto H, Nakatsuma K, Shimada T, Ushimaru S, Mikuri M, Yamazaki T, et al. Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement. J Invasive Cardiol. 2014;26:580\u20135.","journal-title":"J Invasive Cardiol"},{"key":"3182_CR20","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.jacc.2015.08.034","volume":"66","author":"H Matsumoto","year":"2015","unstructured":"Matsumoto H, Ushimaru S, Matsuda T, Shimada T, Mikuri M, Takahashi H, et al. Is caffeine abstention necessary before adenosine-induced fractional flow reserve measurement? J Am Coll Cardiol. 2015;66:1943\u20135.","journal-title":"J Am Coll Cardiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3182-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3182-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3182-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:14:09Z","timestamp":1580170449000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3182-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3182"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3182-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"5 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study is conducted in accordance with the Declaration of Helsinki. Wakayama Medical University Institutional Review Board approved the final version of the protocol (version 1.1) prior to the start of the study (approval number: 2234). This study was registered on the University Hospital Medical Information Network Clinical Trials Registry (UMIN000031526). Written informed consent will be obtained from all participants in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"84"}}